Skip to content
PATRE
  • Start
  • SYNGAP1
  • Sunflower
  • FOXG1
  • Registration
  • Consent
  • IQSEC2

First data from our SYNGAP1 drug survey available

21. June 202326. July 2021 by Administrator

We are excited to announce that the first data from our SYNGAP1 medication survey is available.

Our data were presented in an EPICare webinar by our team member Celina von Stülpnagel. You can watch it here (after registration) and download the slides here.

Categories Allgemein Leave a comment
Newer posts
← Previous Page1 Page2

About

PATRE is a standardized procedure for researching the phenotype and therapies of rare epilepsies based on information directly from the patients and their parents. 
The goal is to create a patient-based registry and natural history studies of participating diseases using Web 4.0 technology.
For our electronic parent questionnaires PATRE uses a server with REDCap for secure state of the art data collection.

 

The project leaders are Kirsten Eschermann and Lorenz KiwullORCID iD icon.

 

As part of PMU Salzburg, PATRE is a collaborating partner of European reference network ERN EpiCare.

 

PATRE is partly funded by the European Union participating in EURAS.

 

  • Facebook

Impressum / Legal notice

© 2026 PATRE • Built with GeneratePress